Purchases and Sales Made in Q2 2024 in Sutro Biopharma, Inc. (STRO)
This table provides information about the institutional ownership of Sutro Biopharma, Inc. (STRO) during Q2 2024. The information is specifically focused on institutions that hold shares of SUTRO BIOPHARMA, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-262K- 47.61% |
$764K - $1.39M
|
288K
$748K
|
|
|
Aug 14, 2024
Q2 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-374K- 7.9% |
$1.09M - $1.99M
|
4.36M
$11.3M
|
|
|
Aug 14, 2024
Q2 2024
|
Aquilo Capital Management, LLC
San Francisco, CA |
SELL
|
- |
-403K- 34.58% |
$1.18M - $2.15M
|
762K
$1.98M
|
|
|
Aug 14, 2024
Q2 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-489K- 43.53% |
$1.43M - $2.61M
|
634K
$1.65M
|
|
|
Aug 14, 2024
Q2 2024
|
Bio Impact Capital LLC
Cambridge, MA |
SELL
|
- |
-1.05M- 25.71% |
$3.08M - $5.61M
|
3.04M
$7.91M
|